Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Improving and standardizing metabolic screening for people prescribed antipsychotic medication who are at risk of developing metabolic syndrome within the community mental health setting

D. Hackett; C. Fitzgerald Improving and standardizing metabolic screening for people prescribed antipsychotic medication who are at risk of developing metabolic syndrome within the community mental health setting International journal of mental health nursing
Metabolic Syndrome

Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication

A. Carballedo; A. Doran; M. Doyle; S. Flavin; J. Tyrrel; F. Kelly; S. Guerin; P. Dodd Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication Ir J Psychol Med
Metabolic Syndrome

Exposure-response analyses of liraglutide 3.0 mg for weight management

J. P. Wilding; R. V. Overgaard; L. V. Jacobsen; C. B. Jensen; C. W. le Roux Exposure-response analyses of liraglutide 3.0 mg for weight management Diabetes Obes Metab

Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis

P. M. Ryan; S. Seltzer; N. E. Hayward; D. A. Rodriguez; R. T. Sless; C. P. Hawkes Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis J Pediatr

Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients

M. Suliman; A. Buckley; A. Al Tikriti; T. Tan; C. W. le Roux; N. Lessan; M. Barakat Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients Diabetes Obes Metab

Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial

J. S. Tronieri; T. A. Wadden; O. A. Walsh; R. I. Berkowitz; N. Alamuddin; K. Gruber; S. Leonard; A. M. Chao Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial Metabolism

Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein beta up-regulation

L. A. Powell; P. Crowe; C. Kankara; J. McPeake; D. R. McCance; I. S. Young; E. R. Trimble; A. McGinty Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein beta up-regulation Clinical science
Insulin Resistance & Diabetes

The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross sectional study

L. Patterson; F. Kee; C. Hughes; D. O'Reilly The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross sectional study BMC Public Health

Prescribing for weight loss in primary care: evidence from a population based study

L. Patterson; C. Patterson; F. Kee; C. Hughes; M. Donnelly; D. O'Reilly Prescribing for weight loss in primary care: evidence from a population based study J Epidemiol Community Health

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

X. Pi-Sunyer; A. Astrup; K. Fujioka; F. Greenway; A. Halpern; M. Krempf; D. C. Lau; C. W. le Roux; R. Violante Ortiz; C. B. Jensen; J. P. Wilding A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management N Engl J Med

Older posts

Newer posts

← Previous Page1 … Page13 Page14 Page15 … Page23 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2025 ASOI